Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab
Deadline - May 10, 2026
GT reference number - 81986990
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 81986990
Document Type - Tender Notices
Description - Description: Section 130a Paragraph 8 SGB V allows the health insurance companies (KK) andpharmaceutical companies, framework discount agreements at the expense of theMedicinal products to be supplied by statutory health insurance. The GWQ is calledS ociety for Efficiency and Quality at KK in accordance with Section 130a Paragraph 8 Sentence 5 SGBVfor their shareholders and customers funds. With regard to the relevantLegal regulations for the award of public contracts are held regularlyProcess of active ingredient-related, formal procurement procedures according to the regulations of the 4th.Part of the GWB takes place by GWQ ServicePlus AG. Until new ones come into forceThe GWQ would like to
Gt Ref Id - 81986990
Deadline - May 10, 2026
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database